Xenon Pharmaceuticals Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
XENE on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 3650 Gilmore Way, Burnaby, British Columbia, Canada

Insiders trading volume in the past year

Xenon Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael R. Hayden Director $3.18M Jun 3, 2021
Frank A. Holler Director $1.43M May 27, 2021
Michael M. Tarnow Director $768K May 18, 2021
Mohammad Azab Director $731K Dec 19, 2023
Ian Mortimer PRESIDENT & CEO, Director $449K Mar 11, 2024
Sherrington Robin EVP, Strategy & Innovation $389K -$330K -45.9% Mar 11, 2024
Gary Patou Director $280K -$312K -52.7% Jun 5, 2024
Dawn Svoronos Director $246K Jun 5, 2024
Steven Gannon Director $92.4K -$602K -86.7% Jun 5, 2024
Simon N. Pimstone Director $59.1K Jun 2, 2023
Elizabeth A. Garofalo Director $0 -$95.6K -100% Jun 5, 2024
Christopher John Kenney Chief Medical Officer Mar 11, 2024
Patrick Machado Director Jun 5, 2024
Justin D. Gover Director Jun 5, 2024
Sherry Aulin Chief Financial Officer Mar 11, 2024
Gillian Cannon Director Jun 5, 2024
Christopher Von Seggern Chief Commercial Officer Mar 11, 2024
James R. Empfield EVP, Drug Discovery Mar 11, 2024
Andrea DiFabio Chief Legal Officer Mar 11, 2024

Recent Insider Transactions by Companies or Individuals for Xenon Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.